Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Schramm

Showing results (1-10 of 352) with videos related to

Pageof 36
Sort By:
Clinical Liver Disease|August 9, 2019
Autoimmune Hepatitis Beyond Steroids: Effective Trial Design and Attention to Quality of LifeChristoph Schramm
Digestive Diseases and Sciences|November 10, 2019
Concise Commentary: Why Cholangioscopy for Indeterminate Biliary Strictures in PSC Is Still Not Good EnoughChristoph Schramm
The New England Journal of Medicine|August 30, 2018
Bile Acids, the Microbiome, Immunity, and Liver TumorsChristoph Schramm
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 15, 2023
ReplyEhud Zigmond, Christoph Schramm
Hepatology (Baltimore, Md.)|April 28, 2015
Natural killer T cells: novel players in biliary disease?Marcial Sebode, Christoph Schramm
Digestive Diseases (Basel, Switzerland)|December 8, 2015
AIH: Which Alternative for Difficult-to-Treat Patients?Marcial Sebode, Christoph Schramm
Seminars in Immunopathology|October 3, 2018
Sex-related factors in autoimmune liver diseasesDorothee Schwinge, Christoph Schramm
Alimentary Pharmacology & Therapeutics|June 28, 2020
Editorial: gut microbiota profile in patients with autoimmune hepatitis-a clue for adjunctive probiotic therapy? Authors' replyTimur Liwinski, Christoph Schramm
Critical Reviews in Immunology|March 15, 2011
Role of activin A in the induction of Foxp3+ and Foxp3- CD4+ regulatory T cellsSamuel Huber, Christoph Schramm
Journal of Hepatology|August 31, 2025
Tregs going acid - how cholestasis impairs regulatory T cell functionDorothee Schwinge, Christoph Schramm
Pageof 36

Showing results (1-10 of 352) with videos related to

Sort By:
Pageof 36
Clinical Liver Disease|August 9, 2019
Autoimmune Hepatitis Beyond Steroids: Effective Trial Design and Attention to Quality of LifeChristoph Schramm
Digestive Diseases and Sciences|November 10, 2019
Concise Commentary: Why Cholangioscopy for Indeterminate Biliary Strictures in PSC Is Still Not Good EnoughChristoph Schramm
The New England Journal of Medicine|August 30, 2018
Bile Acids, the Microbiome, Immunity, and Liver TumorsChristoph Schramm
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 15, 2023
ReplyEhud Zigmond, Christoph Schramm
Hepatology (Baltimore, Md.)|April 28, 2015
Natural killer T cells: novel players in biliary disease?Marcial Sebode, Christoph Schramm
Digestive Diseases (Basel, Switzerland)|December 8, 2015
AIH: Which Alternative for Difficult-to-Treat Patients?Marcial Sebode, Christoph Schramm
Seminars in Immunopathology|October 3, 2018
Sex-related factors in autoimmune liver diseasesDorothee Schwinge, Christoph Schramm
Alimentary Pharmacology & Therapeutics|June 28, 2020
Editorial: gut microbiota profile in patients with autoimmune hepatitis-a clue for adjunctive probiotic therapy? Authors' replyTimur Liwinski, Christoph Schramm
Critical Reviews in Immunology|March 15, 2011
Role of activin A in the induction of Foxp3+ and Foxp3- CD4+ regulatory T cellsSamuel Huber, Christoph Schramm
Journal of Hepatology|August 31, 2025
Tregs going acid - how cholestasis impairs regulatory T cell functionDorothee Schwinge, Christoph Schramm
Pageof 36